サマリー

JE不活化ワクチンの世界市場規模は、2022年の100万米ドルから2029年には100万米ドルになると予測されており、2023年から2029年までのCAGRは %と予測されています。
JE不活化ワクチンの米国市場は、2023年から2029年までのCAGR %で、2022年の100万米ドルから2029年には100万米ドルまで増加すると予測されています。
JE不活化ワクチンの中国市場は、2023年から2029年までのCAGR %で、2022年の100万米ドルから2029年には100万米ドルに増加すると推定されます。
JE不活化ワクチンのヨーロッパ市場は、2023年から2029年にかけてのCAGR %で、2022年の100万米ドルから2029年には100万米ドルに増加すると推定されます。
世界の主要なJE不活化ワクチンプレーヤーは、Bharat Biotech、Biological E. Limited、Biken、Sequirus、Liaoning Chengda、Valneva Austria GmbHなどです。収益面では、世界の2大企業が2022年にほぼ％のシェアを占めています。
不活性化ワクチンはより安全
LPI（エルピーアイ）の最新リサーチレポート「JE不活化ワクチン産業予測」は、過去の販売実績から2022年の世界のJE不活化ワクチン総販売量を検証し、2023年から2029年のJE不活化ワクチン販売予測について地域や市場分野ごとに包括的な分析を提供しています。本レポートでは、JE不活化ワクチンの売上を地域別、市場分野別、サブセクター別に分類し、世界のJE不活化ワクチン産業の詳細な分析（百万米ドル）を提供します。
本インサイトレポートでは、世界のJE不活化ワクチンの状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにしています。また、JE不活化ワクチンのポートフォリオと能力、市場参入戦略、市場ポジション、地理的フットプリントに焦点を当てた主要グローバル企業の戦略を分析し、加速する世界のJE不活化ワクチン市場におけるこれらの企業の独自のポジションをより良く理解することができます。
本インサイトレポートでは、JE不活化ワクチンの世界的な見通しを形成する主要な市場動向、推進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別の予測に分け、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、本調査予測は、世界のJE不活化ワクチンの現状と将来の軌道について非常にニュアンスのある見解を提供します。
本レポートでは、JE不活化ワクチン市場の製品タイプ、用途、主要メーカー、主要地域・国別の包括的な概要、市場シェア、成長機会について紹介します。
市場のセグメンテーション
タイプ別セグメンテーション
ハムスター腎臓細胞
ベロ細胞
用途別セグメンテーション
病院
診療所
また、本レポートでは、地域別に市場を分割しています：
米州
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
中近東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した上で選定されています。
バーラト・バイオテック（Bharat Biotech
バイオロジカルE.リミテッド
ビケン
セキリュス
遼寧省成大
バルネバ オーストリア社
本レポートで取り上げる主な質問
世界のJE不活化ワクチン市場の10年後の展望はどのようなものか？
世界および地域別に、JE不活化ワクチン市場の成長を促進する要因は何か？
市場別、地域別に最も急成長する技術は何か？
JE不活化ワクチンの市場機会はエンドマーケットの規模によってどのように変化するのか？
JE不活化ワクチンのタイプ別、用途別内訳は？
COVID-19とロシア・ウクライナ戦争の影響力は？

ページTOPに戻る

目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global JE Inactivated Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for JE Inactivated Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for JE Inactivated Vaccine by Country/Region, 2018, 2022 & 2029
2.2 JE Inactivated Vaccine Segment by Type
2.2.1 Hamster Kidney Cells
2.2.2 Vero Cells
2.3 JE Inactivated Vaccine Sales by Type
2.3.1 Global JE Inactivated Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global JE Inactivated Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global JE Inactivated Vaccine Sale Price by Type (2018-2023)
2.4 JE Inactivated Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 JE Inactivated Vaccine Sales by Application
2.5.1 Global JE Inactivated Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global JE Inactivated Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global JE Inactivated Vaccine Sale Price by Application (2018-2023)
3 Global JE Inactivated Vaccine by Company
3.1 Global JE Inactivated Vaccine Breakdown Data by Company
3.1.1 Global JE Inactivated Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global JE Inactivated Vaccine Sales Market Share by Company (2018-2023)
3.2 Global JE Inactivated Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global JE Inactivated Vaccine Revenue by Company (2018-2023)
3.2.2 Global JE Inactivated Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global JE Inactivated Vaccine Sale Price by Company
3.4 Key Manufacturers JE Inactivated Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers JE Inactivated Vaccine Product Location Distribution
3.4.2 Players JE Inactivated Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for JE Inactivated Vaccine by Geographic Region
4.1 World Historic JE Inactivated Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global JE Inactivated Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global JE Inactivated Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic JE Inactivated Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global JE Inactivated Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global JE Inactivated Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas JE Inactivated Vaccine Sales Growth
4.4 APAC JE Inactivated Vaccine Sales Growth
4.5 Europe JE Inactivated Vaccine Sales Growth
4.6 Middle East & Africa JE Inactivated Vaccine Sales Growth
5 Americas
5.1 Americas JE Inactivated Vaccine Sales by Country
5.1.1 Americas JE Inactivated Vaccine Sales by Country (2018-2023)
5.1.2 Americas JE Inactivated Vaccine Revenue by Country (2018-2023)
5.2 Americas JE Inactivated Vaccine Sales by Type
5.3 Americas JE Inactivated Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC JE Inactivated Vaccine Sales by Region
6.1.1 APAC JE Inactivated Vaccine Sales by Region (2018-2023)
6.1.2 APAC JE Inactivated Vaccine Revenue by Region (2018-2023)
6.2 APAC JE Inactivated Vaccine Sales by Type
6.3 APAC JE Inactivated Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe JE Inactivated Vaccine by Country
7.1.1 Europe JE Inactivated Vaccine Sales by Country (2018-2023)
7.1.2 Europe JE Inactivated Vaccine Revenue by Country (2018-2023)
7.2 Europe JE Inactivated Vaccine Sales by Type
7.3 Europe JE Inactivated Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa JE Inactivated Vaccine by Country
8.1.1 Middle East & Africa JE Inactivated Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa JE Inactivated Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa JE Inactivated Vaccine Sales by Type
8.3 Middle East & Africa JE Inactivated Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of JE Inactivated Vaccine
10.3 Manufacturing Process Analysis of JE Inactivated Vaccine
10.4 Industry Chain Structure of JE Inactivated Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 JE Inactivated Vaccine Distributors
11.3 JE Inactivated Vaccine Customer
12 World Forecast Review for JE Inactivated Vaccine by Geographic Region
12.1 Global JE Inactivated Vaccine Market Size Forecast by Region
12.1.1 Global JE Inactivated Vaccine Forecast by Region (2024-2029)
12.1.2 Global JE Inactivated Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global JE Inactivated Vaccine Forecast by Type
12.7 Global JE Inactivated Vaccine Forecast by Application
13 Key Players Analysis
13.1 Bharat Biotech
13.1.1 Bharat Biotech Company Information
13.1.2 Bharat Biotech JE Inactivated Vaccine Product Portfolios and Specifications
13.1.3 Bharat Biotech JE Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bharat Biotech Main Business Overview
13.1.5 Bharat Biotech Latest Developments
13.2 Biological E. Limited
13.2.1 Biological E. Limited Company Information
13.2.2 Biological E. Limited JE Inactivated Vaccine Product Portfolios and Specifications
13.2.3 Biological E. Limited JE Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Biological E. Limited Main Business Overview
13.2.5 Biological E. Limited Latest Developments
13.3 Biken
13.3.1 Biken Company Information
13.3.2 Biken JE Inactivated Vaccine Product Portfolios and Specifications
13.3.3 Biken JE Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Biken Main Business Overview
13.3.5 Biken Latest Developments
13.4 Seqirus
13.4.1 Seqirus Company Information
13.4.2 Seqirus JE Inactivated Vaccine Product Portfolios and Specifications
13.4.3 Seqirus JE Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Seqirus Main Business Overview
13.4.5 Seqirus Latest Developments
13.5 Liaoning Chengda
13.5.1 Liaoning Chengda Company Information
13.5.2 Liaoning Chengda JE Inactivated Vaccine Product Portfolios and Specifications
13.5.3 Liaoning Chengda JE Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Liaoning Chengda Main Business Overview
13.5.5 Liaoning Chengda Latest Developments
13.6 Valneva Austria GmbH
13.6.1 Valneva Austria GmbH Company Information
13.6.2 Valneva Austria GmbH JE Inactivated Vaccine Product Portfolios and Specifications
13.6.3 Valneva Austria GmbH JE Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Valneva Austria GmbH Main Business Overview
13.6.5 Valneva Austria GmbH Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

図表リスト

List of Tables
Table 1. JE Inactivated Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. JE Inactivated Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Hamster Kidney Cells
Table 4. Major Players of Vero Cells
Table 5. Global JE Inactivated Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global JE Inactivated Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global JE Inactivated Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global JE Inactivated Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global JE Inactivated Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global JE Inactivated Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global JE Inactivated Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global JE Inactivated Vaccine Revenue by Application (2018-2023)
Table 13. Global JE Inactivated Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global JE Inactivated Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global JE Inactivated Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global JE Inactivated Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global JE Inactivated Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global JE Inactivated Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global JE Inactivated Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers JE Inactivated Vaccine Producing Area Distribution and Sales Area
Table 21. Players JE Inactivated Vaccine Products Offered
Table 22. JE Inactivated Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global JE Inactivated Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global JE Inactivated Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global JE Inactivated Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global JE Inactivated Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global JE Inactivated Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global JE Inactivated Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global JE Inactivated Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global JE Inactivated Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas JE Inactivated Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas JE Inactivated Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas JE Inactivated Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas JE Inactivated Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas JE Inactivated Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas JE Inactivated Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC JE Inactivated Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC JE Inactivated Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC JE Inactivated Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC JE Inactivated Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC JE Inactivated Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC JE Inactivated Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe JE Inactivated Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe JE Inactivated Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe JE Inactivated Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe JE Inactivated Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe JE Inactivated Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe JE Inactivated Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa JE Inactivated Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa JE Inactivated Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa JE Inactivated Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa JE Inactivated Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa JE Inactivated Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa JE Inactivated Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of JE Inactivated Vaccine
Table 58. Key Market Challenges & Risks of JE Inactivated Vaccine
Table 59. Key Industry Trends of JE Inactivated Vaccine
Table 60. JE Inactivated Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. JE Inactivated Vaccine Distributors List
Table 63. JE Inactivated Vaccine Customer List
Table 64. Global JE Inactivated Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global JE Inactivated Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas JE Inactivated Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas JE Inactivated Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC JE Inactivated Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC JE Inactivated Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe JE Inactivated Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe JE Inactivated Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa JE Inactivated Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa JE Inactivated Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global JE Inactivated Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global JE Inactivated Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global JE Inactivated Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global JE Inactivated Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Bharat Biotech Basic Information, JE Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Bharat Biotech JE Inactivated Vaccine Product Portfolios and Specifications
Table 80. Bharat Biotech JE Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Bharat Biotech Main Business
Table 82. Bharat Biotech Latest Developments
Table 83. Biological E. Limited Basic Information, JE Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Biological E. Limited JE Inactivated Vaccine Product Portfolios and Specifications
Table 85. Biological E. Limited JE Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Biological E. Limited Main Business
Table 87. Biological E. Limited Latest Developments
Table 88. Biken Basic Information, JE Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Biken JE Inactivated Vaccine Product Portfolios and Specifications
Table 90. Biken JE Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Biken Main Business
Table 92. Biken Latest Developments
Table 93. Seqirus Basic Information, JE Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Seqirus JE Inactivated Vaccine Product Portfolios and Specifications
Table 95. Seqirus JE Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Seqirus Main Business
Table 97. Seqirus Latest Developments
Table 98. Liaoning Chengda Basic Information, JE Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Liaoning Chengda JE Inactivated Vaccine Product Portfolios and Specifications
Table 100. Liaoning Chengda JE Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Liaoning Chengda Main Business
Table 102. Liaoning Chengda Latest Developments
Table 103. Valneva Austria GmbH Basic Information, JE Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Valneva Austria GmbH JE Inactivated Vaccine Product Portfolios and Specifications
Table 105. Valneva Austria GmbH JE Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Valneva Austria GmbH Main Business
Table 107. Valneva Austria GmbH Latest Developments
List of Figures
Figure 1. Picture of JE Inactivated Vaccine
Figure 2. JE Inactivated Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global JE Inactivated Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global JE Inactivated Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. JE Inactivated Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Hamster Kidney Cells
Figure 10. Product Picture of Vero Cells
Figure 11. Global JE Inactivated Vaccine Sales Market Share by Type in 2022
Figure 12. Global JE Inactivated Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. JE Inactivated Vaccine Consumed in Hospital
Figure 14. Global JE Inactivated Vaccine Market: Hospital (2018-2023) & (K Units)
Figure 15. JE Inactivated Vaccine Consumed in Clinic
Figure 16. Global JE Inactivated Vaccine Market: Clinic (2018-2023) & (K Units)
Figure 17. Global JE Inactivated Vaccine Sales Market Share by Application (2022)
Figure 18. Global JE Inactivated Vaccine Revenue Market Share by Application in 2022
Figure 19. JE Inactivated Vaccine Sales Market by Company in 2022 (K Units)
Figure 20. Global JE Inactivated Vaccine Sales Market Share by Company in 2022
Figure 21. JE Inactivated Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global JE Inactivated Vaccine Revenue Market Share by Company in 2022
Figure 23. Global JE Inactivated Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global JE Inactivated Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas JE Inactivated Vaccine Sales 2018-2023 (K Units)
Figure 26. Americas JE Inactivated Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC JE Inactivated Vaccine Sales 2018-2023 (K Units)
Figure 28. APAC JE Inactivated Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe JE Inactivated Vaccine Sales 2018-2023 (K Units)
Figure 30. Europe JE Inactivated Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa JE Inactivated Vaccine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa JE Inactivated Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas JE Inactivated Vaccine Sales Market Share by Country in 2022
Figure 34. Americas JE Inactivated Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas JE Inactivated Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas JE Inactivated Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC JE Inactivated Vaccine Sales Market Share by Region in 2022
Figure 42. APAC JE Inactivated Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC JE Inactivated Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC JE Inactivated Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe JE Inactivated Vaccine Sales Market Share by Country in 2022
Figure 53. Europe JE Inactivated Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe JE Inactivated Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe JE Inactivated Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa JE Inactivated Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa JE Inactivated Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa JE Inactivated Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa JE Inactivated Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country JE Inactivated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of JE Inactivated Vaccine in 2022
Figure 71. Manufacturing Process Analysis of JE Inactivated Vaccine
Figure 72. Industry Chain Structure of JE Inactivated Vaccine
Figure 73. Channels of Distribution
Figure 74. Global JE Inactivated Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global JE Inactivated Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global JE Inactivated Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global JE Inactivated Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global JE Inactivated Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global JE Inactivated Vaccine Revenue Market Share Forecast by Application (2024-2029)